Pharmacy

5 Takeaways From the European Society of Cardiology 2020 Congress

September 02, 2020

The 2020 meeting, presented in a virtual format from its original host city of Amsterdam, The Netherlands, had lots of important science and a record number of viewers.

MHE 2020 Annual Pharmacy Survey pt. 3

July 31, 2020

As it has done with so much else in healthcare, COVID-19 dominated our 2020 annual pharmacy survey. The disease was addressed in 10 of our 13 areas we covered, either within the question itself or as a possible answer. Third of three parts. See more in our Surveys tab.

MHE 2020 Annual Pharmacy Survey pt. 2

July 30, 2020

As it has done with so much else in healthcare, COVID-19 dominated our 2020 annual pharmacy survey. The disease was addressed in 10 of our 13 areas we covered, either within the question itself or as a possible answer. Second of three parts. See more in our Surveys tab.

MHE 2020 Annual Pharmacy Survey

July 28, 2020

As it has done with so much else in healthcare, COVID-19 dominated our 2020 annual pharmacy survey. The disease was addressed in 10 of our 13 areas we covered, either within the question itself or as a possible answer. First of three parts. See more in our Surveys tab.

Opinion: The Future of Pharmacy Care Services, Post-Pandemic

July 27, 2020

Senior Vice President and Chief Pharmacy Officer for Optum Rx and member of the Managed Healthcare Executive® Editorial Advisory Board, David Calabrese, provides his commentary on the future of pharmacy care services after the coronavirus pandemic.

Eric Levin talks PBMs and how Scripta is Tackling the Market's Challenges for Patients

July 22, 2020

MHE's Briana Contreras spoke with CEO of Scripta, Eric Levin. The two discussed the current state of the pharmacy benefit market and how the Scripta organization has been assisting its clients and their prescriptions prior to the COVID-19 pandemic and during.

How COVID has Shaped Consumer Health, Prescription Drug Trends

July 20, 2020

SingleCare analyzed consumer prescription demand and fill data in the weeks leading up to shelter in place orders, beginning in March, and the subsequent months after the pandemic to see how COVID has impacted the healthcare trends of Americans.

Unlocking The Power of Data Intelligence for The Pharmacy

July 13, 2020

From staffing to readmissions to diagnostics, data intelligence is poised to revolutionize healthcare.

David Calabrese of OptumRx Talks Top Three Drugs in Pipeline, Industry Trends in Q2

July 01, 2020

In this week's episode of Tuning Into The C-Suite podcast, MHE's Briana Contreras chatted with David Calabrese, R.Ph, MHP, who is senior vice president and chief pharmacy officer of pharmacy care services company, OptumRx. David is also a member of Managed Healthcare Executives’ Editorial Advisory Board. During the discussion, he shared the OptumRx Quarter 2 Drug Pipeline Insights Report of 2020. Some of the information shared includes the three notable drugs currently being reviewed or those that have been recently approved by the FDA. Also discussed were any interesting industry trends to watch for.

High Hopes for Inclisiran. Will the Third Time be the Charm for PCSK9 Inhibition?

June 22, 2020

The two PCSK9 inhibitors have fallen far short of expectations. Inclisiran, which works by RNA inference, only needs to be injected twice a year. 

4 Ways PBMs are Changing

June 22, 2020

Pharmacy benefit managers are taking steps to be more responsible for the total cost of care and to become more transparent, while adding technology tools to support patients, payers and physicians in a post-COVID-19 world.

The Pharmaceutical Industry’s Role in a COVID-19 Vaccine

June 11, 2020

Drug makers around the world are racing to develop the first effective COVID-19 vaccine. Early efforts show promise, but an anticipated jump in the novel coronavirus cases in the fall means the sooner a vaccine is developed, the more lives can be saved-and the pharmaceutical industry plays a major role in this discovery.

Siponimod Enters Crowded Market of DMTs for SPMS

June 04, 2020

The Institute for Clinical and Economic Review (ICER) found siponimod has benefits for patients with active secondary progressive multiple sclerosis, but its benefits were in line with other therapies in a crowded marketplace.

AstraZeneca’s Tagrisso Keeps Most Lung Cancer Patients With Mutation Alive Two Years After Surgery

June 01, 2020

Tagrisso, the targeted therapy made by AstraZeneca, could become the treatment of choice for the majority of lung cancer patients with mutations in a certain gene who are treated after surgery, based on findings presented this past weekend at the American Society of Clinical Oncology annual meeting.

Martin VanTrieste Leads the Way at Civica Rx

May 21, 2020

He was reluctant to take the CEO job, but VanTrieste has the unique nonprofit drug manufacturer surpassing its goals and possibly branching out into the retail market.

Claim Analysis By Specialty Pharmacist Saves Health Plan $2.7 Million, Study Finds

May 20, 2020

A new study highlights the role a qualified specialty pharmacist can play in driving down costs across a health plan.

Adherence to Disease-Modifying Drugs Lowers Chronic Opioid Use in Patients with Inflammatory Conditions

May 19, 2020

A study of patients with inflammatory conditions who were prescribed biologic disease-modifying anti-rheumatic drugs had lower rates of chronic opioid use if they were adherent to their biologic therapy, according to new research.

The Taiwan Example: Community Pharmacists Helped Keep COVID-19 Deaths, Cases Way Down

April 13, 2020

Taiwan has had only 6 COVID-19-related deaths. The country used community pharmacists to subdue the outbreak.

What Are the Top Pharma Challenges Right Now?

April 11, 2020

The opioid epidemic is far from over, but it may slip behind other challenges. COVID-19 obviously tops the list of new problems and drug pricing and affordability will continue to soak up time and attention.